Clorox (CLX): Strong Dividend Leader with a Wide Moat Facing ERP Shift—Does a 63% P/E Reduction Make It a Bargain?

Dividend Aristocrats: Revisiting the Value Approach

Last year, a straightforward value strategy was put to the test: selecting Dividend Aristocrats trading well below their estimated worth. The April 1, 2025 article highlighted Northwest Natural (NWN), Archer Daniels Midland (ADM), and PepsiCo (PEP). Over the next twelve months, two of these picks outperformed the S&P 500, which posted a 15.9% gain.

Archer Daniels Midland led the pack, with its stock surging about 54% as the market reassessed its value after years of accounting concerns. Northwest Natural climbed roughly 30%, buoyed by a major acquisition and favorable rate changes. PepsiCo saw a smaller, but still positive, increase, supported by its rising dividend. All three shared resilient dividend growth, clear short-term challenges, and undervalued prices relative to their normalized earnings. The value framework proved effective.

This disciplined method is now being reapplied, aiming to uncover three new Dividend Aristocrats with similarly attractive undervaluation. The latest selections are Clorox (CLX), Genuine Parts (GPC), and McCormick & Co. (MKC). Each faces distinct headwinds that have weighed on their share prices, yet all boast strong competitive advantages and a track record of uninterrupted dividend growth. The central question is whether the market will again overlook temporary setbacks and recognize their enduring value.

Clorox (CLX): Resilience Amidst a Downturn

Clorox shares have dropped nearly 38% over the past year, reaching their lowest point in more than a decade. For value investors, such a steep decline signals caution—but it may also present opportunity. The challenge is to distinguish between short-term difficulties and the company's lasting strengths.

Most of Clorox's current issues stem from internal and cyclical factors. The company is undergoing a multi-year transformation, modernizing its outdated systems. This overhaul led to unusually high shipments at the end of fiscal 2025, resulting in excess inventory and dampened demand as the new year began. Management has openly projected a 5% to 9% drop in organic sales and lower earnings for fiscal 2026, framing this as a planned reset rather than a fundamental flaw.

Despite these challenges, Clorox's competitive moat remains intact. The company owns a portfolio of leading brands, with about 80% holding top positions in their categories—from Clorox bleach to Hidden Valley Ranch and Brita filters. To adapt to shifting consumer preferences, Clorox is offering smaller, more affordable packages and bulk options, helping maintain market share during periods of reduced spending.

Valuation now offers a notable cushion. Clorox trades at a P/E ratio of 18.03, well below its ten-year average of 48.78—a 63% discount reflecting pessimism about near-term earnings, largely due to the ERP transition. However, the dividend story is different: Clorox continues to increase its payout, boasting a 4.9% yield and a 25-year streak of dividend growth, indicating strong cash flow despite temporarily depressed earnings.

This scenario is classic value investing: a robust competitive advantage temporarily overshadowed by a painful but known transition. The low price offers a chance to acquire a wide-moat business at a fraction of its historical valuation. Risks include prolonged ERP challenges or further declines in consumer spending. Yet, for those willing to wait, the combination of high yield, reliable dividend history, and deeply discounted valuation makes a compelling case for patience.

Genuine Parts (GPC): Managing Change and Uncertainty

Genuine Parts has experienced notable volatility, with shares dropping 19% in a single week following a disappointing quarterly report and revised profit outlook for 2026. Despite this, its five-year total shareholder return stands at 30.5%, highlighting the tension between short-term setbacks and long-term business strength.

The company’s core operations provide a formidable moat. Genuine Parts runs an extensive network of over 10,800 locations, serving as a vital supplier for automotive and industrial replacement parts. This reach locks in customer relationships and generates steady cash flow, exemplifying the value of a distributor with a strong competitive edge.

The recent sell-off is tied to two main factors: soft profit guidance for 2026 and plans to split the company into two public entities. While the split may ultimately benefit shareholders, it introduces uncertainty and short-term risk, leading investors to price in potential distractions and execution challenges.

Financially, Genuine Parts remains solid. The sharp decline has pushed its stock below average analyst price targets, suggesting the market may be overly pessimistic about near-term prospects. The company’s history of consistent dividend growth and its resilient service model support the view that the discount is more about temporary noise than fundamental weakness.

In essence, Genuine Parts is a high-quality business facing a transitional period. The split could cause short-term volatility but may unlock value by allowing each entity to focus on its growth drivers. For patient investors, the current price may offer an attractive entry point, betting that the market will eventually recognize the company’s enduring cash flow and competitive advantages once the transition is complete.

McCormick & Co. (MKC): Strength in Pricing and Margins

McCormick’s stock has been volatile, dropping about 13% in the past month after gaining 8% in the previous three months. This fluctuation reflects the market’s struggle to balance immediate challenges with the company’s long-term strengths. For value investors, the focus is on the business’s durability.

McCormick’s competitive position is anchored by its portfolio of iconic brands—such as McCormick, Lawry’s, and Simply Asia—which command significant pricing power in the global spice and flavoring market. This advantage is now evident in the company’s financial results: management has implemented effective cost-saving and pricing strategies, leading to a 150 basis point increase in gross margins, a clear sign of operational discipline.

Looking ahead, McCormick expects constant currency sales growth of 5%-7% and operating profit growth of 10%-12% for the upcoming fiscal year. The gap between sales and profit growth highlights the company’s ability to expand margins and leverage pricing power. Its diverse portfolio and international presence help cushion against regional slowdowns.

However, challenges remain. The second quarter saw a 6% year-over-year drop in EPS, mainly due to weaker performance in the Consumer segment. The outlook for the second half includes nearly flat volumes, with a 1.5% decline expected in the fourth quarter. These issues, particularly sluggish recovery in China and soft volumes in the Americas, are real. Still, McCormick is addressing them with a clear plan, using pricing strategies to offset volume declines.

Ultimately, McCormick’s resilience stands out. Its brand strength and pricing power enable it to create value through economic cycles. The recent volatility appears to be a reaction to temporary volume softness, while the market may be overlooking ongoing margin improvements. Trading below average analyst targets, the stock reflects built-in pessimism. For patient investors, this presents an opportunity to own a wide-moat business with a proven record of earnings and dividend growth, even as it navigates a challenging environment.

Valuation, Catalysts, and Outlook

Clorox, Genuine Parts, and McCormick all trade at substantial discounts to their intrinsic values, but the timeline for a market re-rating is uncertain. Patient investors should focus on the specific catalysts and risks that could drive recognition of these companies’ underlying strengths.

• Clorox: The upcoming first quarter earnings report on April 21, 2026 will be a key test of the turnaround plan post-ERP transition. While management expects a tough year, signs of stabilization or early cost savings could restore confidence. The main risk is a prolonged consumer spending slowdown, but the 4.9% dividend yield and strong brand portfolio provide a safety net.
• Genuine Parts: The planned split into two public companies is a complex catalyst, introducing uncertainty and operational risk. Investors will look for clarity on the split’s timeline and rationale. The company’s vast network offers a durable moat, but short-term distractions may impact performance. The discount to analyst targets reflects this transition risk.
• McCormick: The catalyst is successful execution of its growth forecasts—constant currency sales growth of 5%-7% and operating profit growth of 10%-12%. The challenge is navigating flat volumes, especially in China and the Americas, while converting cost savings into margin expansion. Persistent volume pressures could limit earnings growth and keep the stock undervalued.

All three companies are exposed to broader consumer spending risks. A recession or sustained drop in discretionary purchases would impact earnings, delay recoveries, and likely keep valuations low. However, each possesses a strong competitive moat—whether through brand leadership, an extensive distributor network, or pricing power—that should enable them to create value over time. The key for investors is to distinguish between temporary disruptions and lasting damage. At present, the market seems to be overreacting to known, transitional challenges. Waiting for these catalysts to unfold, the margin of safety provided by current prices could make patience worthwhile.